ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management
Authors:
- Chrystelle ColasCCChrystelle Colas
- Manon SuerinkMSManon Suerink
- Christian P. KratzCKChristian P. Kratz
- Katharina WimmerKWKatharina Wimmer
- Felipe AndreiuoloFAFelipe Andreiuolo
- Amedeo A. AziziAAAmedeo A. Azizi
- Kevin BeccariaKBKevin Beccaria
- Birgit BurkhardtBBBirgit Burkhardt
Open Access
- 17 October 2024
- journal article
- review article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 32 (12) , 1526-1541
Abstract
Constitutional mismatch repair deficiency (CMMRD), first described 25 years ago, confers an extremely high and lifelong cancer risk, including haematologic, brain, and gastrointestinal tract malignancies, and is associated with several non-neoplastic features. Our understanding of this condition has improved and novel assays to assist CMMRD diagnosis have been developed. Surveillance protocols need adjustment taking into account recent observational prospective studies assessing their effectiveness. Response to immune checkpoint inhibitors and the effectiveness and toxicity of other treatments have been described. An update and merging of the different guidelines on diagnosis and clinical management of CMMRD into one comprehensive guideline was needed. Seventy-two expert members of the European Reference Network GENTURIS and/or the European care for CMMRD consortium and one patient representative developed recommendations for CMMRD diagnosis, genetic counselling, surveillance, quality of life, and clinical management based on a systematic literature search and comprehensive literature review and a modified Delphi process. Recommendations for the diagnosis of CMMRD provide testing criteria, propose strategies for CMMRD testing, and define CMMRD diagnostic criteria. Recommendations for surveillance cover each CMMRD-associated tumour type and contain information on starting age, frequency, and surveillance modality. Recommendations for clinical management cover cancer treatment, management of benign tumours or non-neoplastic features, and chemoprevention. Recommendations also address genetic counselling and quality of life. Based on existing guidelines and currently available data, we present 82 recommendations to improve and standardise the care of CMMRD patients in Europe. These recommendations are not meant to be prescriptive and may be adjusted based on individual decisions.Keywords
This publication has 72 references indexed in Scilit:
- Comprehensive analysis of constitutional mismatch repair deficiency‐associated non‐Hodgkin lymphomas in a global cohortPediatric Blood & Cancer, 2024
- Specific brain MRI features of constitutional mismatch repair deficiency syndrome in children with high-grade gliomasEuropean Radiology, 2024
- Diagnostic accuracy of imaging approaches for early tumor detection in children with Li-Fraumeni syndromePediatric Radiology, 2022
- Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiencyHuman Mutation, 2021
- Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or YoungerClinical Gastroenterology and Hepatology, 2021
- A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytesHuman Mutation, 2019
- Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance ImagingJAMA Oncology, 2017
- Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndromeCancer Letters, 2017
- Germline PMS2 and somatic POLE exonuclease mutations cause hypermutability of the leading DNA strand in biallelic mismatch repair deficiency syndrome brain tumoursThe Journal of Pathology, 2017
- Simple Detection of Germline Microsatellite Instability for Diagnosis of Constitutional Mismatch Repair Cancer SyndromeHuman Mutation, 2013